Literature DB >> 29218128

Neurobrucellosis Presenting as Pseudotumor Cerebri: First Report from Oman.

Padam P Sharma1, Mangudi V Murali1, Tahsin Hamdi1.   

Abstract

A ten-year-old boy presented to the hospital with body ache and joint pains for two months and headache, vomiting, and skin rash for three days. He was drowsy and lethargic at admission. Physical examination revealed bilateral papilledema. There were no cranial nerve involvement, neuromotor deficit, or signs of meningeal irritation. Computed tomography and magnetic resonance imaging of the brain did not reveal any evidence of cerebral edema or space occupying lesion. In view of the high endemicity of brucellosis in the area, Brucella agglutination test (BAT) was done at the time of admission and was negative. However, on the eighth day of admission, blood culture showed growth of Brucella melitensis. A repeat BAT at this time was strongly positive with a titer of 1:1 280. The initial one was negative due to prozone phenomenon caused by very high antibody titers. A diagnosis of neurobrucellosis with pseudotumor cerebri was made. He was treated with gentamicin, rifampicin, and septrin along with acetazolamide for raised intracranial pressure. The boy responded well to therapy and made a complete clinical recovery with resolution of papilledema. In areas endemic for brucellosis, a high index of suspicion for neurobrucellosis should be entertained in any child presenting with diverse neurological signs.

Entities:  

Keywords:  Neurobrucellosis; Prozone Phenomenon; Pseudotumor Cerebri

Year:  2017        PMID: 29218128      PMCID: PMC5702994          DOI: 10.5001/omj.2017.96

Source DB:  PubMed          Journal:  Oman Med J        ISSN: 1999-768X


  14 in total

1.  Neurobrucellosis: clinical, diagnostic, therapeutic features and outcome. Unusual clinical presentations in an endemic region.

Authors:  Nurgul Ceran; Recai Turkoglu; Ilknur Erdem; Asuman Inan; Derya Engin; Hulya Tireli; Pasa Goktas
Journal:  Braz J Infect Dis       Date:  2011 Jan-Feb       Impact factor: 1.949

2.  Brucellosis in children of Dhofar Region, Oman.

Authors:  E O El-Amin; L George; N K Kutty; P P Sharma; R S Choithramani; V P Jhaveri; P Salil; S M Bedair
Journal:  Saudi Med J       Date:  2001-07       Impact factor: 1.484

3.  Neurobrucellosis in children.

Authors:  M M Lubani; K I Dudin; G F Araj; D S Manandhar; F Y Rashid
Journal:  Pediatr Infect Dis J       Date:  1989-02       Impact factor: 2.129

4.  Neurobrucellosis: clinical and diagnostic features.

Authors:  Tumer Guven; Kenan Ugurlu; Onder Ergonul; Aysel Kocagul Celikbas; Sebnem Eren Gok; Selcuk Comoglu; Nurcan Baykam; Basak Dokuzoguz
Journal:  Clin Infect Dis       Date:  2013-02-27       Impact factor: 9.079

5.  Isolated intracranial hypertension: a rare presentation of neurobrucellosis.

Authors:  Handan Isin Ozisik; Yasemin Ersoy; Mehmet Refik Tevfik; Sibel Kizkin; Cemal Ozcan
Journal:  Microbes Infect       Date:  2004-07       Impact factor: 2.700

6.  Neurobrucellosis in an endemic area of brucellosis.

Authors:  Hürrem Bodur; Ayse Erbay; Esragül Akinci; Aylin Colpan; Mustafa A Cevik; Neriman Balaban
Journal:  Scand J Infect Dis       Date:  2003

7.  Presentation, complications, and treatment outcome of brucellosis in Turkish children.

Authors:  Gonul Tanir; Sehra B Tufekci; Nilden Tuygun
Journal:  Pediatr Int       Date:  2009-02       Impact factor: 1.524

8.  Neurobrucellosis: clinical and therapeutic features.

Authors:  D R McLean; N Russell; M Y Khan
Journal:  Clin Infect Dis       Date:  1992-10       Impact factor: 9.079

9.  An uncommon case of pediatric neurobrucellosis associated with intracranial hypertension.

Authors:  Xenophon Sinopidis; Joseph Kaleyias; Konstantina Mitropoulou; Maria Triga; Sanjeev V Kothare; Stefanos Mantagos
Journal:  Case Rep Infect Dis       Date:  2012-07-29

10.  A Rare presentation of neurobrucellosis in a child with Recurrent transient ischemic attacks and pseudotumor cerebri (A case report and review of literature).

Authors: 
Journal:  Iran J Child Neurol       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.